+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Lymphoma"

Chronic Lymphocytic Leukemia (CLL) - Product Thumbnail Image

Chronic Lymphocytic Leukemia (CLL)

  • Report
  • May 2021
  • 79 Pages
  • Global
Market Spotlight: Hodgkin's Lymphoma - Product Thumbnail Image

Market Spotlight: Hodgkin's Lymphoma

  • Report
  • May 2021
  • 44 Pages
  • Global
Market Spotlight: NHL: Peripheral T-cell lymphoma (PTCL) - Product Thumbnail Image

Market Spotlight: NHL: Peripheral T-cell lymphoma (PTCL)

  • Report
  • May 2021
  • 39 Pages
  • Global
Market Spotlight: Waldenström Macroglobulinemia (WM) - Product Thumbnail Image

Market Spotlight: Waldenström Macroglobulinemia (WM)

  • Report
  • May 2021
  • 41 Pages
  • Global
Market Spotlight: Cutaneous T-Cell Lymphoma (CTCL) - Product Thumbnail Image

Market Spotlight: Cutaneous T-Cell Lymphoma (CTCL)

  • Report
  • May 2021
  • 45 Pages
  • Global
Diffuse Large B-cell Lymphoma (DLBCL) - Competitive Landscape in 2021 - Product Thumbnail Image

Diffuse Large B-cell Lymphoma (DLBCL) - Competitive Landscape in 2021

  • Report
  • January 2021
  • 51 Pages
  • Global
From
B-Cell Non-Hodgkin's Lymphoma (NHL): Opportunity Analysis and Forecasts to 2027 - Product Thumbnail Image

B-Cell Non-Hodgkin's Lymphoma (NHL): Opportunity Analysis and Forecasts to 2027

  • Report
  • June 2019
  • 147 Pages
  • Global
From
Hodgkin's Lymphoma - Opportunity Analysis and Forecasts to 2029 - Product Thumbnail Image

Hodgkin's Lymphoma - Opportunity Analysis and Forecasts to 2029

  • Report
  • June 2020
  • 140 Pages
  • Global
From
Malignant Lymphoma Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Malignant Lymphoma Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • August 2023
  • 74 Pages
  • Global
From
Lymphoma Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology - Product Thumbnail Image

Lymphoma Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology

  • Report
  • February 2022
  • 83 Pages
  • Global
From
American Society of Clinical Oncology (ASCO) Annual Meeting, 2019 Assessment Report - Product Thumbnail Image

American Society of Clinical Oncology (ASCO) Annual Meeting, 2019 Assessment Report

  • Report
  • June 2019
  • 130 Pages
  • United States
2024 World Hematology and Flow Cytometry Database: 98 Countries - Analyzers and Reagents, Supplier Shares, Test Volume and Sales Segment Forecasts - Product Thumbnail Image

2024 World Hematology and Flow Cytometry Database: 98 Countries - Analyzers and Reagents, Supplier Shares, Test Volume and Sales Segment Forecasts

  • Report
  • March 2024
  • Global
From
2024 Europe Hematology and Flow Cytometry Database: 38 Countries - Analyzers and Reagents, Supplier Shares, Test Volume and Sales Segment Forecasts - Product Thumbnail Image

2024 Europe Hematology and Flow Cytometry Database: 38 Countries - Analyzers and Reagents, Supplier Shares, Test Volume and Sales Segment Forecasts

  • Report
  • March 2024
  • Europe
From
2024 Global Hematology and Flow Cytometry Database: US, Europe, Japan - Analyzers and Reagents, Supplier Shares, Test Volume and Sales Segment Forecasts - Product Thumbnail Image

2024 Global Hematology and Flow Cytometry Database: US, Europe, Japan - Analyzers and Reagents, Supplier Shares, Test Volume and Sales Segment Forecasts

  • Report
  • March 2024
  • Japan, United States, ... Japan, United States, Europe, Global
From
2024 Middle East Hematology and Flow Cytometry Database: 11 Countries - Analyzers and Reagents, Supplier Shares, Test Volume and Sales Segment Forecasts - Product Thumbnail Image

2024 Middle East Hematology and Flow Cytometry Database: 11 Countries - Analyzers and Reagents, Supplier Shares, Test Volume and Sales Segment Forecasts

  • Report
  • March 2024
  • Middle East
From
2024 Asia-Pacific Hematology and Flow Cytometry Database: 18 Countries - Analyzers and Reagents, Supplier Shares, Test Volume and Sales Segment Forecasts - Product Thumbnail Image

2024 Asia-Pacific Hematology and Flow Cytometry Database: 18 Countries - Analyzers and Reagents, Supplier Shares, Test Volume and Sales Segment Forecasts

  • Report
  • March 2024
  • Asia Pacific
From
2024 Latin America Hematology and Flow Cytometry Database: 22 Countries - Analyzers and Reagents, Supplier Shares, Test Volume and Sales Segment Forecasts - Product Thumbnail Image

2024 Latin America Hematology and Flow Cytometry Database: 22 Countries - Analyzers and Reagents, Supplier Shares, Test Volume and Sales Segment Forecasts

  • Report
  • March 2024
  • Latin America
From
2024 North America Hematology and Flow Cytometry Database: US, Canada, Mexico - Analyzers and Reagents, Supplier Shares, Test Volume and Sales Segment Forecasts - Product Thumbnail Image

2024 North America Hematology and Flow Cytometry Database: US, Canada, Mexico - Analyzers and Reagents, Supplier Shares, Test Volume and Sales Segment Forecasts

  • Report
  • March 2024
  • Canada, Mexico, North America Canada, Mexico, North America
From
2024 Europe Hematology and Flow Cytometry Database: France, Germany, Italy, Spain, UK - Analyzers and Reagents, Supplier Shares, Test Volume and Sales Segment Forecasts - Product Thumbnail Image

2024 Europe Hematology and Flow Cytometry Database: France, Germany, Italy, Spain, UK - Analyzers and Reagents, Supplier Shares, Test Volume and Sales Segment Forecasts

  • Report
  • March 2024
  • France, Germany, ... France, Germany, Italy, Spain, United Kingdom, Europe
From
2024 US Hematology and Flow Cytometry Database: Analyzers and Reagents, Supplier Shares, Test Volume and Sales Segment Forecasts - Product Thumbnail Image

2024 US Hematology and Flow Cytometry Database: Analyzers and Reagents, Supplier Shares, Test Volume and Sales Segment Forecasts

  • Report
  • March 2024
  • United States
From
Loading Indicator

Lymphoma is a type of hematological malignancy that originates in the lymphatic system. It is characterized by the uncontrolled growth of lymphocytes, a type of white blood cell. Lymphomas can be either Hodgkin's or non-Hodgkin's, and can be either indolent or aggressive. Treatment options for lymphoma include chemotherapy, radiation therapy, stem cell transplantation, and targeted therapies. The lymphoma market is a subset of the larger hematology market, which includes treatments for a variety of blood-related diseases. The lymphoma market is driven by the increasing prevalence of the disease, as well as the development of new treatments. Companies in the lymphoma market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Celgene, Gilead Sciences, Novartis, and Pfizer. Show Less Read more